StockPriceToday
Zscaler Inc (ZS)
About Zscaler Inc
Zscaler Inc. provides cloud-based cybersecurity solutions that enable secure internet access and application connectivity for organizations worldwide. The company's cloud-native security approach has made ZS stock price sensitive to enterprise cloud adoption and cybersecurity spending trends.
Zscaler's Zero Trust Exchange platform routes and inspects all internet traffic through its global cloud infrastructure, providing protection against cyber threats while enabling secure access to applications and data. The company's solutions replace traditional network security appliances with cloud-delivered services.
The company's software-as-a-service model creates recurring revenue streams while its global cloud infrastructure provides scalable security services. Zscaler's focus on securing remote work and cloud applications aligns with evolving enterprise IT requirements, positively affecting ZS stock price movements.
Zscaler's expansion into data protection, digital experience monitoring, and cloud security posture management demonstrates its commitment to providing comprehensive security solutions. The company's ability to innovate and scale its platform while competing against established cybersecurity vendors remains crucial for its continued growth and market positioning.
ZS Stock 12 Month Chart
Latest News for ZS
ZS is positioned to benefit from secular zero-trust security adoption, boasting 23%+ revenue growth, ~32% FCF margins, and a $1.65bn net cash buffer. I see 49% upside over 2.2 years driven by market ...
Palo Alto Networks currently generates substantially higher absolute revenue than Zscaler. Both companies demonstrated generally consistent quarter-over-quarter revenue growth over the last eight ...
Zscaler Inc (NASDAQ:ZS) is one of the 8 Best Cloud Computing Stocks To Buy In 2026. On May 1, Citizens analyst Trevor Walsh lowered his price target on Zscaler Inc.
Other Popular Stocks
Monolithic Power Systems Inc. (MPWR) is a semiconductor company designing and manufacturing high-performance analog and mixed-signal semiconductors for various electronic applications.
Apellis Pharmaceuticals Inc. is a biotechnology company developing complement pathway therapies for rare diseases and other serious conditions.
Neurocrine Biosciences Inc. (NBIX) is a biotechnology company developing and commercializing neurological and endocrine therapies for serious diseases affecting the central nervous system.